Published: 2018-12-08

Articles

BUILDING A STRUCTURED MONITORING AND EVALUATING SYSTEM OF POSTMARKETING DRUG USE IN SHANGHAI

Wenmin Du, Mitchell Levine, Longxing Wang, Chengdong Yi, Hongmin Wang, Xiaoyu Wang, Hongjuan Xie Xie, Jianglong Xu, Huilin Jin, Tongchun Wang, Gang Huang, Ye Wu
Abstract 246 | PDF Downloads 152
PDF

COUNSELING REGARDING PREGNANCY- RELATED DRUG EXPOSURES BY FAMILY PHYSICIANS IN ONTARIO

Jodi Goodwin, Scott Rieder, Michael J Rieder, Doreen Matsui
Abstract 183 | PDF Downloads 99
PDF

45 YEARS LATER… WHERE DO WE STAND?

Mercédes Benegbi
Abstract 163 | PDF Downloads 87
PDF

PAEDIATRIC ADVERSE DRUG REACTION REPORTING: UNDERSTANDING AND FUTURE DIRECTIONS

Bruce C Carleton, M Anne Smith, Michaela N Gelin, Susan C Heathcote
Abstract 471 | PDF Downloads 233
PDF

ESTABLISHING A NEW BENCHMARK FOR DRUG EVALUATION DURING PREGNANCY

Gideon Koren
Abstract 629 | PDF Downloads 84
PDF

DRUGS IN PREGNANCY: ACKNOWLEDGING CHALLENGES - FINDING SOLUTIONS

Gideon Koren, Stuart MacLeod, Donald Davis
Abstract 814 | PDF Downloads 129
PDF

DRUGS USED IN PREGNANCY: THE REGULATORY PROCESS

Anne Tomalin
Abstract 193 | PDF Downloads 319
PDF

THE WAY WOMEN PERCEIVE TERATOGENIC RISK

Gideon Koren
Abstract 862 | PDF Downloads 294
PDF

INACTIVE PHARMACEUTICAL INGREDIENTS: IMPLICATIONS FOR PREGNANCY

Yaron Finkelstein, Massoud Rezvani, Facundo Garcia-Bournissen, Laila Nurmohamed, Gideon Koren
Abstract 1491 | PDF Downloads 703
PDF

CHALLENGES IN DRUG USE NEAR TERM AND DURING DELIVERY

Dan Farine
Abstract 156 | PDF Downloads 100
PDF

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 137 | PDF Downloads 85
PDF

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 158 | PDF Downloads 75
PDF

CRITICAL APPRAISAL ROUNDS: A NEW TRAINING MODEL FOR CLINICAL PHARMACOLOGISTS

Gideon Koren, Irena Nulman
Abstract 812 | PDF Downloads 108
PDF

USE OF CELECOXIB IMMEDIATELY POST MARKETING IN CANADA: ACUTE OR CHRONIC PAI N?

Anita L Kozyrskyj, Colette Raymond, Amber Racher Racher
Abstract 200 | PDF Downloads 132
PDF

ESTABLISHING A NEW BENCHMARK FOR DRUG EVALUATION DURING PREGNANCY

Gideon Koren
Abstract 859 | PDF Downloads 82
PDF